News

Resveratrol is a naturally occurring polyphenolic antioxidant found in over 70 plant species. Resveratrol has been demonstrated to extend lifespan and improve healthspan in a variety of animal species.

To prevent employee theft, an expert recommends closely monitoring cash for and financial records, beefing up internal controls and keeping an eye on employees facing unusual pressures.

New wound-healing tools arising from evolving knowledge of the wound-healing process include drugs, debridement techniques, advanced skin grafting tools and stem cell delivery strategies.

Practice stability enhanced by reforms

Adam DeGraide CEO at Crystal Clear Digital Marketing, LLC, sits down with Dr. Robert Marshall, medical director at Rejuvenate Med Spa to discuss the value of properly branding a medical practice online, from designing a website, logos and much more.

New research data sheds light on potential gene therapy for congenital melanocytic nevi.

High-powered CO2 lasers are making news in scar remodeling. The devices allow dermatologists to go deep into the scar, increase scar mobility and even encourage normal skin formation in the treated area, according to this expert presenter.

It might seem counter-intuitive - even scary - but patients and their dermatologists should consider laser therapy as a first-line approach for treating laser and intense pulsed light (IPL)-induced scarring and dyspigmentation.

Novel uses for tried-and-true laser and energy-based technologies are improving the treatment of darker skin types and outcomes for a variety of skin conditions, according to a presentation by New York City-based dermatologist Roy G. Geronemus, M.D., and colleagues at yesterday’s American Society for Laser Medicine & Surgery 2015 annual conference in Kissimmee, Fla.

Technologies and techniques dermatologists use to treat vascular lesions in children are improving, resulting in better outcomes for young patients, according to a presentation by New York City-based dermatologist Roy G. Geronemus, M.D., and colleagues at yesterday’s American Society for Laser Medicine & Surgery 2015 annual conference in Kissimmee, Fla.

It might seem unlikely, but researchers have found the antihypertensive drug spironolactone reduces skin atrophy from topical corticosteroid use.

Laser tattoo removal is booming, experts say, even among patients at extremes of the age spectrum. However, removing trendy lip- and eyeliner tattoos can be tricky because they often contain iron oxide or titanium dioxide.

A 16-year-old lifeguard was being treated for acne and is now complaining of this nail problem occurring for the past few weeks.

Many patients with chronic acne seek unusual treatments. Do they work?

Time Sawyer, President & Co-Founder of Crystal Clear Digital Marketing talks with Deborah Freeman MacDonald of R.E., Inc. The two discuss the value of using social media to connect with customers.

National Institutes of Health researchers found that clindamycin and trimethoprim–sulfamethoxazole (TMP-SMX) work equally well to treat uncomplicated skin infections, including cellulitis and abscesses.

A study comparing concentrations of abobotulinum toxin A and onabotulinum toxin A for reduction of forehaead wrinkles found that and increased dilution of abobotulinum toxin A results in a greater surface area coverage.

Clues about genetic alterations that underlie their disease.

SLNB and GEP combined – powerful predictors of metastatic risk. Learn more on the studies results.

TNF inhibitors shown to be effective in improving the clinical symptoms of moderate to severe hidradenitis suppurativa, representing an exciting therapeutic option for this challenging disease.

The FDA approved Gardasil 9 as a preventive measure against cervical, vulvar, vaginal, and anal cancers caused by HPV types 16, 18, 31, 33, 45, 52, and 58, and to prevent genital warts caused by HPV types 6 or 11.

A new study suggests that patients whose melanoma tumors have a high number of genetic mutations might respond best to drugs that block CTLA-4.

Melanoma is a genetically heterogeneous condition that will likely result in more diversified clinical management in the future.

Short ALA incubation coupled with blue light therapy yields effective, pain-free results.

Although relatively few physicians perform nonsurgical eye lifts, combining fillers and neuromodulators in this area can yield excellent results and high patient satisfaction, according to one international expert who presented at last year’s Cosmetic Bootcamp in Aspen, Colo.

Who would have thought that the cure for Methicilin-resistant Staphylococcus aureus (MRSA) may have been hiding in a book written in the 10th century?

Two of the most vexing skin conditions that dermatologists manage are melasma and vitiligo. In one condition, too much pigmentation is present because of genetic, hormonal and environmental factors. In the other, there is a lack of melanin in the skin, presumably on an autoimmune basis. In part two of this discussion on dyspigmentation conditions, Seemal Desai, M.D., who is a board-certified dermatologist, clinical assistant professor in the department of dermatology at University of Texas, Southwestern Medical Center in Dallas, and medical director of Innovative Dermatology, discusses treatment options for vitiligo with Dermatology Times editorial advisor, Dr. Norman Levine.

Indigo naturalis is an Old-World plant with multiple uses. Used in China for centuries as a traditional medicine, current clinical studies are proving its effectiveness as well as identifying mechanisms of action.

Electronic surface brachytherapy is a low-energy radiation treatment for skin cancer. Radiologists are required to administer the treatment, which is controversial in terms of reimbursement and collaborative requirements.

FDA has approved dinutuximab (Unituxin, United Therapeutics) in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of high-risk pediatric neuroblastoma patients who achieve at least a partial response to prior first-line multiagent, multimodality therapy.